竹内 仁

• 血液悪性疾患における分子生物学的研究
• 白血病の治療
• Molecular biologic study on hematological malignancies
• Treatment for leukemia

• Kunio Kitamura, Takahiro Nishiyama, Ken Ishiyama, Shuichi Miyawaki, Kanji Miyazaki, Kenshi Suzuki, Hiroaki Masaie, Masaya Okada, Hiroyasu Ogawa, Kiyotoshi Imai, et al. Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral blood. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2016. 103. 1. 53-62
• Rajeev Mishra, Takayoshi Watanabe, Makoto T. Kimura, Nobuko Koshikawa, Maki Ikeda, Shota Uekusa, Hiroyuki Kawashima, Xiaofei Wang, Jun Igarashi, Diptiman Choudhury, et al. Identification of a novel E-box binding pyrrole-imidazole polyamide inhibiting MYC-driven cell proliferation. CANCER SCIENCE. 2015. 106. 4. 421-429
• Yujin Kobayashi, Yoshihiro Hatta, Masahiko Sugitani, Atsuko Hojo, Masaru Nakagawa, Machiko Kusuda, Yoshihito Uchino, Hiromichi Takahashi, Satomi Kiso, Yukio Hirabayashi, et al. Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma. LEUKEMIA & LYMPHOMA. 2014. 55. 11. 2514-2519
• Noriyoshi Iriyama, Bo Yuan, Yuta Yoshino, Yoshihiro Hatta, Akira Horikoshi, Shin Aizawa, Masami Takei, Jin Takeuchi, Norio Takagi, Hiroo Toyoda. Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid. INTERNATIONAL JOURNAL OF ONCOLOGY. 2014. 44. 3. 865-873
• 竹内 仁. Efficacy of Molecular Response at 1 or 3 Months after the Initiation of Dasatinib Treatment Can Predict an Improved Response to Dasatinib in Imatinib-Resistant or Imatinib-Intolerant Japanese Patients with Chronic Myelogenous Leukemia during the Chronic P. J Clin Exp Hematop. 2014. 54. 3. 197-204

もっと見る

• Masamitsu Yanada, Saiko Kurosawa, Takuhiro Yamaguchi, Takuya Yamashita, Yukiyoshi Moriuchi, Hiroatsu Ago, Jin Takeuchi, Hirohisa Nakamae, Jun Taguchi, Toru Sakura, et al. Prognosis of acute myeloid leukemia harboring monosomal karyotype in patients treated with or without allogeneic hematopoietic cell transplantation after achieving complete remission. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL. 2012. 97. 6. 915-918
• Noriyoshi Iriyama, Yoshihiro Matsukawa, Katsuhiro Miura, Hirotake Inomata, Yukio Hirabayashi, Yoshihiro Hatta, Akira Horikoshi, Jin Takeuchi. Efficacy and safety of antifungal prophylaxis with oral itraconazole solution among patients receiving corticosteroids: who should be given prophylaxis?. JOURNAL OF INFECTION AND CHEMOTHERAPY. 2011. 17. 6. 744-749
• Kumi Uenogawa, Yoshihiro Hatta, Naomichi Arima, Satoshi Hayakawa, Umihiko Sawada, Shin Aizawa, Tatsuo Yamamoto, Jin Takeuchi. Azacitidine induces demethylation of p16INK4a and inhibits growth in adult T-cell leukemia/lymphoma. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2011. 28. 5. 835-839
• Yukio Hirabayashi, Yoshihiro Hatta, Jin Takeuchi, Isao Tsuboi, Tomonori Harada, Kentaro Ono, Wilhelm Robert Glomm, Masahiro Yasuda, Shin Aizawa. Novel three-dimensional long-term bone marrow culture system using polymer particles with grafted epoxy-polymer-chains supports the proliferation and differentiation of hematopoietic stem cells. EXPERIMENTAL BIOLOGY AND MEDICINE. 2011. 236. 11. 1342-1350
• Noriyoshi Iriyama, Akira Horikoshi, Toshitake Tanaka, Yukio Hirabayashi, Hitomi Kodaira, Yoshihiro Hatta, Jin Takeuchi. Successful treatment of Hodgkin lymphoma in second trimester of pregnancy: feasibility of ABVD regimen. INTERNATIONAL JOURNAL OF HEMATOLOGY. 2011. 94. 1. 104-107

もっと見る

• 日本血液学会編 血液専門医テキスト
  南江堂 2015
• 急性リンパ性白血病(Ph染色体陽性急性リンパ性白血病を除く) 日本血液学会編 血液専門医テキスト
  南江堂 2011
• ALLの化学療法 木崎昌弘編 白血病・リンパ腫・骨髄腫 第4版
  中外医学社 2011
• 急性リンパ性白血病 血液疾患最新の治療2011-2013
  南江堂 2010
• ALLの治療中,脳実質に径3cmの孤立性腫瘤が発見された.さてどうしよう?。 造血器腫瘍治療 これは困ったぞ,どうしよう!第2版。
  中外医学社 2010

もっと見る

• 急性骨髄性白血病患者における亜ヒ酸代謝の検討。
  (第23回日本微量元素学会学術集会 2012)
• An Intensified Consolidation Program with Dose-Escalated Doxorubicin for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL): A Study by the Japan Adult Leukemia Study Group (JALSG ALL97 study).
  (he 51th Annual Meeting of American Society of Hematology. 2009)
• Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy as Post-Remission Strategy in Elderly Patients with Non-M3 AML in CR1: Retrospective Analysis with 1036 Patients.
  (The 51th Annual Meeting of American Society of Hematology. 2009)
• A Markov Decision Analysis of Post-Remission Strategies in 2029 Patients with AML in First Remission (CR1): Should We Perform Allogeneic Hematopoietic Cell Transplantation in CR1?
  (The 51th Annual Meeting of American Society of Hematology. 2009)
• Prognostic Factor Among Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL).
  (he 51th Annual Meeting of American Society of Hematology. 2009)

もっと見る

• 医学博士 (日本大学)

• 2006/04 - 2013/03 日本大学医学部 血液膠原病内科 教授

• 日本血液学会 評議員
• 日本内科学会 評議員

日本血液学会 ,  国際血液学会 ,  日本内科学会 ,  日本癌学会 ,  日本感染症学会 ,  日本造血細胞移植学会 ,  日本臨床腫瘍学会 ,  The Japanese Society of Hematology ,  International Socienty of Hematology ,  The Japanese Society of Internal Medicine ,  The Japanese Association for Infectious Diseases ,  The Japan Association for hematopoietic Cell Transplantation ,  Japanese Society of Medical Oncology ,  American Society of Hematology ,  The Japanese Society of Hematology ,  International Socienty of Hematology ,  The Japanese Society of Internal Medicine ,  The Japanese Cancer Association ,  The Japanese Association for Infectious Diseases ,  The Japan Association for hematopoietic Cell Transplantation ,  Japanese Society of Medical Oncology ,  American Society of Hematology